{
    "2020-12-09": [
        [
            {
                "time": "2020-12-09",
                "original_text": "机构股东的胜利？沃森“启示录”：资本市场机构化背后的股东“积极主义”",
                "features": {
                    "keywords": [
                        "机构股东",
                        "资本市场",
                        "机构化",
                        "积极主义"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-09",
                "original_text": "连用16个“不存在”：沃森生物127页回复质疑 市场不买账再跌5%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "质疑",
                        "市场反应",
                        "下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-09",
                "original_text": "沃森生物“贱卖”资产疑云：市值三天蒸发近170亿，曾多次出售重金收购资产 连续下跌",
                "features": {
                    "keywords": [
                        "贱卖",
                        "资产",
                        "市值蒸发",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-09",
                "original_text": "科技、白酒和医药，明年三条“赛道”还能继续？",
                "features": {
                    "keywords": [
                        "科技",
                        "白酒",
                        "医药",
                        "赛道"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "白酒",
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-09",
                "original_text": "沃森生物再发声 股权转让有利于公司长远发展",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "股权转让",
                        "长远发展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}